Today's Change
+0.23%
AI Sentiment
59%
Sector AnalysisLive data
Healthcare Sector Outlook
The Healthcare sector is up 0.23% today with neutral sentiment across 17 recent news articles. Top movers include $SRTAW (-86.67%), $NTRBW (+38.64%), $PIIIW (+35.14%).
Bullish Factors
- Predominantly positive news flow
Risk Factors
- No strong bearish signals detected
Stocks in Healthcare
74 stocks| Symbol | Company | Change |
|---|---|---|
| $LUCYW | Innovative Eyewear Inc - Warrants(31/12/2023) | -30.65% |
| $EUDAW | EUDA Health Holdings Limited | -13.69% |
| $TLSIW | TriSalus Life Sciences Inc. | +29.87% |
| $HSCSW | Heart Test Laboratories Inc. Warrant | -8.06% |
| $VSEEW | VSee Health, Inc. | +6.06% |
| $MDAIW | Spectral AI Inc | -1.56% |
| $PIIIW | P3 Health Partners Inc | +35.14% |
| $BBLGW | Bone Biologics Corp Warrants | -13.91% |
| $WGSWW | GeneDx Holdings Corp. | -32.26% |
| $OSRHW | Bellevue Life Sciences Acquisition Corp - Warrants (09/02/2028) | +19.80% |
| $SBCWW | SBC Medical Group Holdings Incorporated | +1.16% |
| $COCHW | Envoy Medical Inc. | -13.79% |
| $TOIIW | The Oncology Institute Inc | +0.00% |
| $NTRBW | Nutriband Inc. Warrant | +38.64% |
| $JNJ | Johnson & Johnson | -0.41% |
Healthcare News
447 articlesGlobeNewswire Inc.15d ago
Mental Health Clinical Trials Research Report 2026: $4.89 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
GlobeNewswire Inc.15d ago
Levicept to Present Data from Phase II study of LEVI-04 at OARSI 2026 World Congress on Osteoarthritis
GlobeNewswire Inc.15d ago
FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss Under National Priority Voucher Program
GlobeNewswire Inc.16d ago
Regeneron Announces Agreement with U.S. Government to Help Lower Drug Costs for American Patients and Will Provide Innovative New Gene Therapy for Free in the U.S.
GlobeNewswire Inc.16d ago
Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report
GlobeNewswire Inc.16d ago
Global Perfusion Systems Market to Register Incremental Growth at a CAGR of ~5% by 2034 | DelveInsight
GlobeNewswire Inc.16d ago
Kymera Therapeutics to Report First Quarter 2026 Financial Results on April 30, 2026
The Motley Fool16d ago
Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins
GlobeNewswire Inc.16d ago
BSX DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - BSX
GlobeNewswire Inc.16d ago
ELV INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Elevance Health, Inc.
Market Sentiment
Neutral
59% Sentiment Score
Sector Stats
Total Stocks74
News Today17
Avg Volume1.1M
AI SentimentNeutral